Prescribing Outside the Exam Room - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.

  • By

  • Kathryn Wighton

  • May 5, 2026

  • 2 min

Share

Objective:

To highlight the case of a physician and his son charged with illegally prescribing controlled substances without patient evaluations, emphasizing the lack of legitimate medical purpose.

Key Findings:
  • Prescriptions for drugs like oxycodone-acetaminophen, dextroamphetamine-amphetamine, and alprazolam were issued electronically without patient evaluations.
  • The physician's actions bypassed standard clinical encounters.
  • The case illustrates a gap in real-time oversight of electronic prescribing systems.
Interpretation:

The reliance on professional integrity in prescribing practices is concerning, highlighting the urgent need for adequate real-time safeguards against misuse.

Limitations:
  • The investigation revealed systemic weaknesses in monitoring prescribing authority, with regulatory interventions occurring only after patterns of abuse were identified.
Conclusion:

There is a need for health systems and regulators to enhance real-time monitoring of prescribing practices to prevent exploitation and harm to patients.

Original Source(s)

Prescribing Outside the Exam Room

  • by Kathryn Wighton

  • May 5, 2026

Related Content

Half of pediatric mental health visits hit smaller EDs

Pediatric suicide-related visits showed a similar distribution, while patient and diagnostic characteristics differed across emergency settings.

988 telecom fees tied to higher crisis funding

State allocations rose over 6 fiscal years but did not vary significantly by suicide death rate.

How does IBD relate to joint infection risk?

Investigators assessed 90-day outcomes among patients with IBD who underwent elective total joint arthroplasty.